301 results about "Suppository drug" patented technology

The anti-infective medicine, including powder, mixture, aerosol, capsule, injection, suppository, ointment and microcapsule, is characterized by that on the theroretical basis of combining traditional Chinese medicine and modern immunology the immunoglobulin, effective components of Chinese medicinal materials which are extracted according to the compound prescription and auxiliary preparation are combined together organically, and undergone the fine preparation process to obtain a high-efficiency, safe, stable, environment-protecting type anti-infection medicine having no toxic side effect and having no drug resistance.

There is disclosed herein a composition for treating gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers diarrhea, chronic idiopathic nausea, IBD-associated constipation and diarrhea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, Parkinsons disease, MS, Alzheimers Disease, Motor Neurone Disease or autism, the composition comprising: (i) at least two anti-clostridial agents selected from the group consisting of: vancomycin, vancomycin derivatives, a multi-valent polymer of vancomycin, aminoglycosides, nitroimidazoles, ansamysins, nifuroxazide, colchicine, prucalopride, prokinetic agent and 5-aminosalicylic acid; or (ii) at least one anti-clostridial agent selected from the above combined with an opioid blocking agent. There is also disclosed herein a method of treating various gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers diarrhea, chronic idiopathic nausea, IBD-associated constipation and diarrhea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, Parkinsons disease, MS, Alzheimers Disease, Motor Neurone Disease or autism, the method comprising administering orally, via enema or by suppository: (i) a composition of the invention; (ii) at least two anti-clostridial agents selected from the group consisting of: vancomycin, vancomycin derivatives, a multi-valent polymer of vancomycin, aminoglycosides, nitroimidazoles, ansamysins, nifuroxazide, colchicine, prucalopride, prokinetic agent and 5-aminosalicylic acid; or (iii) at least one anti-clostridial agent selected from the above and an opioid blocking agent to a patient in need of such treatment.

A dispersing solid (capsule, tablet, particle, suppository and dripping pill) of cyclosporin A is prepared from cyclosporin A and carrier by solvent method, solvent fusion method, etc. It has high solubility of easy absorption.

The invention discloses a yang supplementing five returning ketoside drug for preventing and treating cardio-cerebrovascular diseases, which is prepared by extracting active ingredient from raw materials of hoantchy root, angelica, red paeonia, hemlock parsley, earthworm and peach kernel. The obtained drug has total glucosides of the hoantchy root as 30-60%, total glucosides oftotal glucosides of the red paeonia as 5-20%, content of safflower flavone as 5-10%, and the remains as the other ingredients extracted from the traditional Chinese medicine materials. The yang supplementing five returning ketoside drug provided by the invention can be added with accessories or auxiliary components acceptable in pharmacy to form various preparations required by clinic. The preparations are: small injection solution, transfusion, freeze-dried powder, tablet, capsule, oral solution, buccal tablet, granule, medicinal granules, pill, powder, suspension, suppository, drop, dropping pill, sustained release preparation, release controlling agent and targeting preparation. The drug of the invention has clearly controllable efficacious components, fast absorption, definitive curative effect, convenience for taking and is effective for preventing and treating cardio-cerebral ischemia diseases.

Provided herein are topical formulations containing copper ions and methods of treating radiation dermatitis, damage caused by radiation therapy, or other radiation-induced damage conditions in various areas of the body using such formulations. Methods of treating radiation dermatitis using topical copper ion treatments are provided. A topical treatment in its basic form comprises a biocompatible copper ion solution or suspension obtained by leaching of the copper ions from copper metal. The copper ion solution or suspension is combined with various carriers to form the copper ion treatment including creams, gels, lotions, foams, pastes, tampons, solutions, suppositories, body wipes, wound dressings, skin patches, and suture material. Methods of making the copper ion solution or suspension from solid copper metal in a biocompatible solution are also provided.

The invention belongs to the field of pharmaceutical preparations and particularly discloses a tranexamic acid external semisolid preparation and a preparation method thereof. The semisolid preparation is one of gels, suppositories and ointments prepared from tranexamic acid serving as an active ingredient and other pharmaceutically acceptable auxiliary materials. The tranexamic acid external semisolid preparation disclosed by the invention has high physiological skin compatibility, and the haemostatic effect of the tranexamic acid is effectively improved.

A combination therapy for the treatment of acute myocardial infarction comprises administering a combination of a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof to a patient. The combination synergistically reduces mortality of patients with acute myocardial infarction.

The invention belongs to the field of biomedicine, and particularly relates to an egg yolk antibody of HPV E6 / E7 recombined minicircle DNA and application of the antibody in preparing a drug for treating HPV infection. The egg yolk antibody is obtained by utilizing HPV E6 / E7 recombined minicircle DNA as a nuclear acid antigen for direct immunization of a laying hen. The egg yolk antibody can be used for preparing the drug for treating HPV infection. The egg yolk antibody is prepared into freeze-dried powder and subjected to superfine grinding, after lipidosome encapsulating, a nano-liposome encapsulating the egg yolk antibody is prepared, the antibody enters cells in a transmembrane mode, the high-activity anti-HPV antibody is input to a patient with positive HPV, and E6 / E7 protein in an HPV virus inside the cells is directly neutralized. The antibody is combined with antibacterial active ingredients (antibacterial compounds or gynecologic inflammation pathogen specific antibodies) andacceptable pharmaceutical carriers to be prepared into vagina spraying agents, vagina washing liquor, vagina gels, vagina soft and hard capsules, vagina suppositories, vagina membranes, vagina tablets, effervescent tablets, ointment, creams and the like, and can also be prepared into lozenges, chewable tablets, chewing gums and the like for both male and female.